Page last updated: 2024-09-03

cholestyramine resin and Colicky Pain

cholestyramine resin has been researched along with Colicky Pain in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Collins, NM; Krajicek, EJ; Wan, SH1
Talley, NJ1
Brazg, R; Maciejko, JJ; Patil, S; Rubenfire, M; Shah, A1

Trials

1 trial(s) available for cholestyramine resin and Colicky Pain

ArticleYear
Psyllium for the reduction of cholestyramine-associated gastrointestinal symptoms in the treatment of primary hypercholesterolemia.
    Archives of family medicine, 1994, Volume: 3, Issue:11

    Topics: Abdominal Pain; Adult; Aged; Analysis of Variance; Cholestyramine Resin; Constipation; Diarrhea; Double-Blind Method; Female; Flatulence; Gastrointestinal Diseases; Heartburn; Humans; Hypercholesterolemia; Lipids; Male; Middle Aged; Psyllium

1994

Other Studies

2 other study(ies) available for cholestyramine resin and Colicky Pain

ArticleYear
77-Year-Old Man With Hypothyroidism, Right Upper Quadrant Pain, and Diarrhea.
    Mayo Clinic proceedings, 2016, Volume: 91, Issue:1

    Topics: Abdominal Pain; Aged; Anticholesteremic Agents; Cholecystectomy, Laparoscopic; Cholelithiasis; Cholestyramine Resin; Diarrhea; Drug Administration Schedule; Hormone Replacement Therapy; Humans; Hypothyroidism; Male; Obesity; Pain Measurement; Postoperative Complications; Severity of Illness Index; Thyroxine; Treatment Outcome; Ultrasonography

2016
Board Review Vignette: Irritable Bowel Syndrome.
    The American journal of gastroenterology, 2016, Volume: 111, Issue:9

    Topics: Abdominal Pain; Adult; Anion Exchange Resins; Antidiarrheals; Carbolines; Cholestyramine Resin; Constipation; Diarrhea; Disease Management; Female; Gastrointestinal Agents; Guanylyl Cyclase C Agonists; Humans; Imidazoles; Irritable Bowel Syndrome; Laxatives; Loperamide; Peptides; Phenylalanine; Probiotics; Rifamycins; Rifaximin; Selective Serotonin Reuptake Inhibitors

2016